Skip to main content

Table 2 Preoperative characteristics of the patients

From: Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial

Characteristic

Remifentanil

Dexmedetomidine

n = 47 (50.00%)

n = 47 (50.00%)

Age (years)

49.57 ± 11.09

51.17 ± 10.15

Sex (male/female)

44/3

38/9

Body mass index (kg/m2)

22.73 ± 3.12

21.89 ± 2.65

Baseline AST (U/L)

37.60 ± 14.77

37.36 ± 20.12

Baseline ALT (U/L)

37.68 ± 22.20

35.55 ± 21.91

Baseline ALB (g/L)

40.20 ± 5.05

39.73 ± 4.17

Baseline TBIL (μmol/L)

20.15 ± 15.55

18.29 ± 12.56

Baseline PT (s)

14.46 ± 1.23

14.27 ± 1.59

Baseline PT% activity

85.34 ± 14.42

85.57 ± 14.49

  1. Data are expressed as mean ± standard deviation, or numbers. None of the variables significantly differed between the two groups (P > 0.05)
  2. ALT alanine aminotransferase, AST aspartate aminotransferase, ALB albumin, TBIL total bilirubin, PT prothrombin time